30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Doug Lankler

Track

Insider profile

Currently holds a position at Pfizer Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 23% 68% 82%
Transactions
24 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, General Counsel Pfizer Inc Feb. 1, 2014 -
Executive Vice President, General Counsel, Corporate Secretary Pfizer Inc Jan. 1, 2014 - Feb. 1, 2014
Executive Vice President, General Counsel Pfizer Inc Dec. 1, 2013 - Jan. 1, 2014
Executive Vice President, Chief Compliance and Risk Officer Pfizer Inc Feb. 1, 2011 - Dec. 1, 2013
Doug Lankler's trades of Pfizer Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-13 2022-05-12
US Pfizer Inc (PFE)
S Sale
4,465 +35.6%
471.17
US$4,382,395 		4,465 +35.6% 471.17 US$4,382,395
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
48,527 +24.5%
202.04
US$143,156 		48,527 +24.5% 202.04 US$143,156
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
89,944 +12.2%
392.09
US$279,513 		89,944 +12.2% 392.09 US$279,513
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
5,765 -6.8%
54.40
US$313,616 		5,765 -6.8% 54.40 US$313,616
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
5,203 -5.8%
54.17
US$281,847 		5,203 -5.8% 54.17 US$281,847
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
4,500 -4.8%
54.55
US$245,475 		4,500 -4.8% 54.55 US$245,475
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
4,200 -4.3%
54.50
US$228,900 		4,200 -4.3% 54.50 US$228,900
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
2,736 -2.7%
54.39
US$148,811 		2,736 -2.7% 54.39 US$148,811
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
1,677 -1.6%
54.46
US$91,329 		1,677 -1.6% 54.46 US$91,329
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
1,497 -1.4%
54.47
US$81,542 		1,497 -1.4% 54.47 US$81,542
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
1,133 -1.1%
54.26
US$61,477 		1,133 -1.1% 54.26 US$61,477
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
909 -0.9%
54.45
US$49,495 		909 -0.9% 54.45 US$49,495
2021-11-30 2021-11-26
US Pfizer Inc (PFE)
S Sale
124 -0.1%
54.32
US$6,736 		124 -0.1% 54.32 US$6,736
2020-05-01 2020-04-29
US Pfizer Inc (PFE)
S Sale
57,099 -42.2%
37.83
US$2,160,055 		57,099 -42.2% 37.83 US$2,160,055
2020-05-01 2020-04-29
US Pfizer Inc (PFE)
S Sale
7,901 -5.5%
38.01
US$300,317 		7,901 -5.5% 38.01 US$300,317
2019-02-01 2019-02-01
US Pfizer Inc (PFE)
S Sale
5,000 -11.1%
42.75
US$213,750 		5,000 -11.1% 42.75 US$213,750
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
17,099 -27.5%
41.19
US$704,308 		17,099 -27.5% 41.19 US$704,308
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
9,136 -12.8%
41.20
US$376,403 		9,136 -12.8% 41.20 US$376,403
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
6,000 -7.8%
41.18
US$247,080 		6,000 -7.8% 41.18 US$247,080
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
2,100 -2.6%
41.16
US$86,436 		2,100 -2.6% 41.16 US$86,436
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
1,800 -2.2%
41.15
US$74,070 		1,800 -2.2% 41.15 US$74,070
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
1,500 -1.8%
41.17
US$61,755 		1,500 -1.8% 41.17 US$61,755
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
900 -1.1%
41.22
US$37,098 		900 -1.1% 41.22 US$37,098
2019-02-01 2019-01-30
US Pfizer Inc (PFE)
S Sale
265 -0.3%
41.21
US$10,921 		265 -0.3% 41.21 US$10,921